DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Modi S, Saura C, Yamashita T, Park YH, Kim SB, Tamura K.
Trastuzumab deruxtecan in previously treated HER2-positive breast cancer.
New England J Med 2019;
382: 610-21
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.